Cargando…
Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis
Triple-negative breast cancer (TNBC) is considered to be the most aggressive and malignant neoplasm and is highly metastatic in nature. In the current study, we investigated the anti-metastatic potential of atovaquone, a protozoal drug prescribed for Pneumocystis pneumonia. We showed that atovaquone...
Autores principales: | Gupta, Nehal, Srivastava, Sanjay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229709/ https://www.ncbi.nlm.nih.gov/pubmed/34071408 http://dx.doi.org/10.3390/ph14060521 |
Ejemplares similares
-
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells
por: Gupta, Nehal, et al.
Publicado: (2021) -
Graphene-Induced Osteogenic Differentiation Is Mediated by the Integrin/FAK Axis
por: Xie, Han, et al.
Publicado: (2019) -
Clutching at Guidance Cues: The Integrin–FAK Axis Steers Axon Outgrowth
por: Davis-Lunn, Mathew, et al.
Publicado: (2023) -
Inhibition of HER2-integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression
por: Gupta, Parul, et al.
Publicado: (2014) -
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
por: Xu, B, et al.
Publicado: (2017)